TABLE 2

Baseline characteristics of initially nondiabetic men with and without diabetes at follow-up

No diabetesDiabetesP
n2,692123
Age at screening (years)47.4 ± 2.547.9 ± 1.50.10
Follow-up time (years)6.2 ± 0.96.2 ± 0.90.70
BMI (kg/m2)24.6 ± 3.127.2 ± 3.9<0.001
Glucose (mmol/l)4.7 ± 0.545.1 ± 0.58<0.001
Log HOMA0.53 ± 0.731.01 ± 0.83<0.001
Cholesterol (mmol/l)5.7 ± 1.05.9 ± 1.00.16
Triglycerides (mmol/l)1.5 ± 0.81.9 ± 1.0<0.001
Smokers (%)47490.63
Blood pressure medication (%)4.28.80.01
Heredity for diabetes (%)4.16.30.05
Inflammation-sensitive proteins
    α1-Antitrypsin (g/l)1.28 ± 0.271.30 ± 0.270.63
    Ceruloplasmin (g/l)0.312 ± 0.060.313 ± 0.060.97
    Fibrinogen (g/l)3.47 ± 0.793.61 ± 0.760.02
    Haptoglobin (g/l)1.29 ± 0.651.34 ± 0.560.11
    Orosomucoid (g/l)0.82 ± 0.200.86 ± 0.200.02
Inflammation-sensitive proteins in top quartile (%)
    04328
    12629
    21420
    3 or more1722Trend 0.003
Complement factors
    C3 (g/l)0.98 ± 0.211.12 ± 0.22<0.0001
    C4 (g/l)0.246 ± 0.080.266 ± 0.080.008
  • Data are means ± SE, unless otherwise noted. C3 and C4 were available in 2,702 and 2,704 men, respectively, 117 of whom had incident diabetes.